STRIDES PHARMA INC — Tacrolimus Importer Profile
Pharmaceutical Importer · #16 buyer for Tacrolimus · $1.8M import value · 41 shipments · UNITED STATES · DGFT Verified
STRIDES PHARMA INC is the #16 importer of Tacrolimus from India with $1.8M in import value and 41 verified shipments. STRIDES PHARMA INC holds a 0.5% market share in Tacrolimus imports based in UNITED STATES. The company sources from 1 verified supplier across 39 formulations shipped to 1 country. Overall, STRIDES PHARMA INC imports 12 pharmaceutical products worth $47.3M across 9 therapeutic categories.
STRIDES PHARMA INC — Tacrolimus Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Tacrolimus to STRIDES PHARMA INC?
Verified from 41 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| STRIDES PHARMA SCIENCE LIMITED | $1.8M | 41 | 100.0% |
STRIDES PHARMA INC sources Tacrolimus from 1 verified Indian supplier based on 41 customs records. The primary supplier is STRIDES PHARMA SCIENCE LIMITED accounting for 100.0% of imports.
How Does STRIDES PHARMA INC Compare to Nearest Tacrolimus Importers?
Buyers ranked immediately above and below #16 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 17 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $1.4M | 28 | $50.0K |
| 13 | GLENMARK PHARMACEUTICALS INC | UNITED STATES | $1.3M | 26 | $50.0K |
| 16 | STRIDES PHARMA INC ★ | UNITED STATES | $1.1M | 22 | $50.0K |
| 11 | LEK D D PAKIRNI CENTER LENDAVA TRIMLINI | SLOVENIA | $1.0M | 20 | $50.0K |
| 9 | LEK D D | SLOVENIA | $850.0K | 17 | $50.0K |
STRIDES PHARMA INC ranks #16 among 727 Tacrolimus importers from India. Average shipment value of $50.0K compared to the market average of $70.2K. The closest competitors by value are DR. REDDYS LABORATORIES, INC and GLENMARK PHARMACEUTICALS INC.
Where Does STRIDES PHARMA INC Import Tacrolimus To?
Destination countries from 41 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.8M | 41 | 100.0% |
STRIDES PHARMA INC imports Tacrolimus to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.8M.
What Tacrolimus Formulations Does STRIDES PHARMA INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| TACROLIMUS CAPSULES USP (5MG)(HARD GELAT | $100.0K | 2 |
| Tacrolimus Capsules USP [5mg] [Hard Gela | $90.4K | 2 |
| TACROLIMUS CAPSULES USP 1MG HARD GELATIN 15552 X 100S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 0.5MG HARD GELATIN 15840 X 100S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 1 MG HARD GELATIN. 39024 X 100S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 1 MG HARD GELATIN 11328 X 100S HDPE | $50.0K | 1 |
| Tacrolimus Capsules USP [5mg] [Hard Gelatin 4128.00 X 100'S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP [5MG] [HARD GELATIN 4,128.00 X 100'S HDPE | $50.0K | 1 |
| Tacrolimus Capsules USP [5mg] [Hard Gelatin] 2,112.00X 100'S HDPE | $50.0K | 1 |
| Tacrolimus Capsules USP [1mg] [Hard Gelatin] 10,992.00X 100'SHDPE | $50.0K | 1 |
STRIDES PHARMA INC imports 39 distinct Tacrolimus formulations from India. The top formulation is TACROLIMUS CAPSULES USP (5MG)(HARD GELAT with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Tacrolimus into United States
What STRIDES PHARMA INC and other importers must comply with to import Tacrolimus from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Tacrolimus
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Tacrolimus from India and How Much Does STRIDES PHARMA INC Import?
India exported $51.0M worth of Tacrolimus through 4,611 shipments from 299 suppliers to 127 countries, serving 727 buyers globally. STRIDES PHARMA INC imports $1.8M of this total, accounting for 0.5% of India's Tacrolimus exports with 41 shipments from UNITED STATES. This is verified from 41 customs shipment records covering 39 distinct formulations.
What Is the Average Order Value for STRIDES PHARMA INC's Tacrolimus Imports?
STRIDES PHARMA INC's average Tacrolimus order value is $44.8K per consignment, based on 41 shipments totaling $1.8M. STRIDES PHARMA INC is based in UNITED STATES and ranks #16 among all Tacrolimus importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Tacrolimus to STRIDES PHARMA INC?
STRIDES PHARMA INC sources Tacrolimus from 1 verified Indian supplier: STRIDES PHARMA SCIENCE LIMITED ($1.8M, 100.0%). This is based on 41 customs records.
How Does STRIDES PHARMA INC Compare to Other Tacrolimus Importers?
STRIDES PHARMA INC ranks #16 among 727 Tacrolimus importers from India with a 0.5% market share. The top 3 importers are LEK D.D ($9.8M), SANDOZ INC. C/O EXEL, INC. ($9.6M), EVERSANA LIFE SCIENCES SERVICES,LLC ($7.1M). STRIDES PHARMA INC processed 41 shipments from UNITED STATES.
What Other Immunosuppressants Products Does STRIDES PHARMA INC Import?
STRIDES PHARMA INC also imports these immunosuppressants products. Each links to the detailed product page.
About STRIDES PHARMA INC
STRIDES PHARMA INC imports 12 products worth $47.3M. Beyond Tacrolimus, top products include Iron, Prednisone, Mycophenolate, Hydrocortisone, Ibuprofen. View the complete STRIDES PHARMA INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tacrolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tacrolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: STRIDES PHARMA INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as STRIDES PHARMA INC's capped import value divided by total capped export value for Tacrolimus across all Indian exporters.
- 5.Verified Records: This page is backed by 41 individual customs records matching STRIDES PHARMA INC importing Tacrolimus, covering 39 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 127+ countries, 727+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tacrolimus Import Data for STRIDES PHARMA INC
Access order-level details, pricing data, supplier connections, and competitive analysis for STRIDES PHARMA INC's Tacrolimus imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
STRIDES PHARMA INC
Full Company Profile →
12 products · $47.3M total trade · 9 categories
STRIDES PHARMA INC × Tacrolimus
Verified from customs records
Company Overview
Top Products by STRIDES PHARMA INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for STRIDES PHARMA INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tacrolimus. For current order-level data, contact TransData Nexus.